From Covaxin clinical trials to risk in indoor spaces, here are the top updates on coronavirus. Bharat Biotech has said that it will conduct phase 4 clinical trials of Covaxin and phase 3 clinical trials data will be released in July. Meanwhile, a study suggested that there is a greater risk of spreading virus in indoor spaces while speaking without masks. Also, another study by ICMR-NIV found that Covaxin can neutralize Delta and Beta variants. Watch the full video for more updates on the pandemic.

Also read – https://www.hindustantimes.com/india-news/problems-of-students-vaccinated-with-indigenously-developed-covaxin-raised-with-us-101623263289835.html

#Covid #Vaccine #Variants

source

By earmpy

33 thoughts on “Covid update: Mask & indoor spaces risk; vaccines against Delta, Beta variants”
  1. पेट्रोल चला सो के पार
    चलो हो जाएँ साइकिल पर सवार

    🚲🚲🚲🚲🚲🚲🚲🚲🚲🚲🚲🚲🚲
    Up.2022

  2. Virus risk in indoor spaces very high so for the sake of safety measures shut the cinema halls for another one year ..in view of public interest

  3. Are the writers really high.. They always write smthng wrong.. This time it is 92 lakh cases in 24 hours? Ssly. So many times i have noticed. Times group is Really unprofessional

  4. CALL IT RIGHT WING PANDEMIC WHERE WORLD IS DIVIDED AS LEFT AND RIGHT..RIGHT WING WANTS POLICE CONTROLLED LOCKDOWN CORONA..WHILE REST OF 245 NATIONS WANT NATURAL IMMUNISATION ..SO GUYS UNITE AGAINST RIGHT WING MANIACS

Leave a Reply

Your email address will not be published. Required fields are marked *